I absolutely think this stock is going to run hard after approval rather than being sold off like most other companies achieve after great news. . .
At the moment, we haven't seen the volume buying of deep pockets - funds.
They simply can't buy because it would be a misappropriation of funds if approval did not occur! Can you imagine the manager explaining to his boss? He took a educated gamble on FDA approval?
After approval the numbers will speak for themselves and they are quite compelling.
BOT - Anything but charting, page-8530
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $572.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.0¢ | $1.366M | 4.341M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 342765 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 723414 | 18 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |